Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorTHOMAS, Aline
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorPROUST-LIMA, Cecile
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBAILLET, Marion
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorHELMER, Catherine
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDELCOURT, Cecile
ORCID: 0000-0002-2099-0481
IDREF: 035105291
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorSAMIER FOUBERT, Alexandra
dc.contributor.authorCATHELINE, G.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorFEART-COURET, Catherine
ORCID: 0000-0002-7959-1610
IDREF: 08195848X
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorSAMIERI, Cecilia
dc.date.accessioned2021-03-22T10:45:56Z
dc.date.available2021-03-22T10:45:56Z
dc.date.issued2020-09-30
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26763
dc.description.abstractEnBackground & aims: Carotenoids are vegetable pigments with neuroprotective properties. Clinical studies found efficacy of specific carotenoids on improving brain perfusion and functioning with aging. However, evidence of an effect on neurodegeneration, which may require longer follow-up period to observe, is more limited. Leveraging biomarkers from a large population-based cohort study of older adults, we investigated whether blood carotenoids were associated with atrophy of the medial temporal lobe (a biomarker of neurodegeneration in aging) over 10 years. Methods: This study included 461 dementia-free participants from the Three-City Bordeaux study (aged ≥65) who had plasma carotenoids measured at baseline and up to three repeated brain imaging exams in the subsequent 10 years. Results: In adjusted linear mixed models, each increase of 1 SD in plasma level of total carotenoids and of β-carotene was associated with 0.02 cm3 (95% CI, 0.001–0.04; P = 0.04) and 0.02 cm3 (95% CI, 0.01–0.04; P = 0.008) smaller medial temporal lobe volume loss per year, respectively. Conclusions: Our results based on a unique long-term prospective evaluation of a neuroimaging biomarker suggest a beneficial role of carotenoids for the prevention of age-related neurodegeneration. © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism
dc.language.isoENen_US
dc.title.enPlasma carotenoids and medial temporal lobe atrophy in older adults
dc.title.alternativeClin Nutren_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.clnu.2020.09.056en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed33558180en_US
bordeaux.journalClinical Nutritionen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamSEPIAen_US
bordeaux.teamBIOSTAT_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03176300
hal.version1
hal.date.transferred2021-03-22T10:46:00Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Clinical%20Nutrition&rft.date=2020-09-30&rft.au=THOMAS,%20Aline&PROUST-LIMA,%20Cecile&BAILLET,%20Marion&HELMER,%20Catherine&DELCOURT,%20Cecile&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée